Meaning we have no clinical evidence that it works
GHK-Cu is in a category of its own compared to other peptides like BPC-157 or Semax, it does not address inflammation or cognitive function in the same way
Gastroenterology 127 , 17981808, doi: 10.1053/j.gastro.2004.09.049 (2004)
FOXO4-DRI works by disrupting the interaction between the FOXO4 protein and p53, enabling p53 to activate apoptosis in senescent cells
Expanding application scope to explore interventions in aging-related diseases (neurodegenerative diseases, cardiovascular diseases, metabolic diseases), providing new strategies for their prevention and treatment
It works systemically, meaning it does not need to be injected near the injury site to be effective